
Strada
Security and trust center evidence
AI agents that run insurance operations
Summary
Strada has 2 registry-verified rows in the CertReports index, last verified 17 Sep 2026. The strongest row is CSA STAR: STAR Level 1 self-assessment (CAIQ). This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.
Reviewer brief
As of 17 Sep 2026, Strada is listed in CSA STAR with a STAR Level 1 self-assessment (CAIQ) issued 26 Feb 2024. As of 17 Sep 2026, Strada is listed in the EU-US Data Privacy Framework registry as active, covering both EU-US Certification and UK Extension Certification, issued 26 Mar 2026 and expiring 26 Mar 2027. As of 17 Sep 2026, no public evidence found for SOC 2 for Strada. As of 17 Sep 2026, no public evidence found for HIPAA for Strada. As of 17 Sep 2026, no public evidence found regarding subprocessors for Strada, as the evidence row indicates a count of 0.
- CSA STAR: listed in registry, STAR Level 1 self-assessment (CAIQ), issued 26 Feb 2024 (as of 17 Sep 2026)
- EU-US Data Privacy Framework: listed in registry as active (EU-US Certification, UK Extension Certification), issued 26 Mar 2026, expires 26 Mar 2027 (as of 17 Sep 2026)
- SOC 2 and HIPAA: no public evidence found for Strada (as of 17 Sep 2026)
Facts only, each dated; nothing here is inferred, scored or advised. Brief generated 17 Sep 2026; it is regenerated whenever a row changes.
Among insurance vendors
2verified rows
Category median 1, across 12 indexed insurance vendors. Strada has more verified rows than 100 percent of them.
agentic-aiclaims-automationinsurance-servicingoperations-automation
Compare with similar vendors
Pick your own comparisonCompliance grid
Legal artefacts
No DPA, BAA or subprocessor list has been captured from a public page yet. Registry rows above do not depend on this. Check the vendor trust centre.
Subprocessors
No subprocessor list captured yet.
Similar vendors with evidence
Related by product tags and the Insurance category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.